JP2759209B2 - Recombinant DNA containing xylanase gene - Google Patents
Recombinant DNA containing xylanase geneInfo
- Publication number
- JP2759209B2 JP2759209B2 JP63195143A JP19514388A JP2759209B2 JP 2759209 B2 JP2759209 B2 JP 2759209B2 JP 63195143 A JP63195143 A JP 63195143A JP 19514388 A JP19514388 A JP 19514388A JP 2759209 B2 JP2759209 B2 JP 2759209B2
- Authority
- JP
- Japan
- Prior art keywords
- xylanase
- recombinant
- strain
- dna
- alkali
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 title claims description 36
- 108020004511 Recombinant DNA Proteins 0.000 title claims description 8
- 241000588724 Escherichia coli Species 0.000 claims description 18
- 239000003513 alkali Substances 0.000 claims description 16
- 239000013611 chromosomal DNA Substances 0.000 claims description 10
- 239000012634 fragment Substances 0.000 claims description 8
- 241000193464 Clostridium sp. Species 0.000 claims description 4
- 241000193403 Clostridium Species 0.000 claims description 3
- 210000000349 chromosome Anatomy 0.000 claims 2
- 101150018420 kbp gene Proteins 0.000 claims 1
- 239000013612 plasmid Substances 0.000 description 22
- 102000004190 Enzymes Human genes 0.000 description 21
- 108090000790 Enzymes Proteins 0.000 description 21
- 229940088598 enzyme Drugs 0.000 description 21
- 239000000243 solution Substances 0.000 description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- 108020004414 DNA Proteins 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 239000002609 medium Substances 0.000 description 15
- 239000000872 buffer Substances 0.000 description 14
- 239000006228 supernatant Substances 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 108091008146 restriction endonucleases Proteins 0.000 description 12
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 10
- 239000007983 Tris buffer Substances 0.000 description 9
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 9
- 229960000723 ampicillin Drugs 0.000 description 9
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 8
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 229920001221 xylan Polymers 0.000 description 8
- 150000004823 xylans Chemical class 0.000 description 8
- 238000012869 ethanol precipitation Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 7
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- 102000016943 Muramidase Human genes 0.000 description 6
- 108010014251 Muramidase Proteins 0.000 description 6
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 6
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 6
- 239000004325 lysozyme Substances 0.000 description 6
- 229960000274 lysozyme Drugs 0.000 description 6
- 235000010335 lysozyme Nutrition 0.000 description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 6
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 229910001629 magnesium chloride Inorganic materials 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 102000006382 Ribonucleases Human genes 0.000 description 4
- 108010083644 Ribonucleases Proteins 0.000 description 4
- 201000004283 Shwachman-Diamond syndrome Diseases 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 235000011056 potassium acetate Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 239000008362 succinate buffer Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000007993 MOPS buffer Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000006456 gs medium Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 108700040099 Xylose isomerases Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- OSFRXFWEODRNCZ-UHFFFAOYSA-M [Cl-].Br.[Cs+] Chemical compound [Cl-].Br.[Cs+] OSFRXFWEODRNCZ-UHFFFAOYSA-M 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002154 agricultural waste Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 102220201851 rs143406017 Human genes 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は耐熱性嫌気性細菌由来の耐熱、耐アルカリ性
キシラナーゼの遺伝情報を担うDNAをベクターに組み込
んだ組換えDNA及び該組換えDNAを導入した大腸菌に関す
るものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a recombinant DNA in which a DNA carrying the genetic information of a heat-resistant and alkali-resistant xylanase derived from a thermotolerant anaerobic bacterium is incorporated into a vector, and the recombinant DNA is introduced. Escherichia coli.
キシラナーゼは農産廃物(ワラ、トウモロコシ茎等)
のヘミセルロースの主体であるキシランを分解する酵素
である。キシランの構成単位であるキシロースについて
はあまり有効な利用面が開発されていなかったが、キシ
ロースイソメラーゼによりキシロースをキシルロースに
変換することが可能となり、酵母がこれを資化し、エタ
ノールに転換できることが明らかにされて以来その利用
が注目されている。Xylanase is agricultural waste (straw, corn stalk, etc.)
Is an enzyme that degrades xylan, which is the main component of hemicellulose. Xylose, a constituent unit of xylan, has not been developed as a very effective surface, but xylose isomerase can convert xylose to xylulose, and it is clear that yeast can utilize it and convert it to ethanol. Its use has been attracting attention since.
キシラナーゼは、上記のような用途として重要な酵素
となっているが、現在では熱やアルカリに弱い酵素が多
く、高温で反応させることは難しい状態である。そのた
め、耐熱、耐アルカリ性のキシラナーゼが求められてお
り、このような酵素を用いれば、高温での処理が可能と
なり、反応時間が短縮されるばかりでなく、雑菌の混入
の恐れも少なくなる。Xylanase is an important enzyme for the above uses, but many enzymes are weak to heat and alkali at present, and it is difficult to react at high temperatures. Therefore, a heat-resistant and alkali-resistant xylanase is required. If such an enzyme is used, treatment at a high temperature becomes possible, and not only the reaction time is shortened, but also the risk of contamination by various bacteria is reduced.
現在、キシラナーゼとしては、バクテロイデス属やク
リプトコッカス属やストレプトミセス属などのものが知
られており、またバチルス属に関してはその遺伝子もク
ローニングされている〔モレキュラー・アンド・ジェネ
ラル・ジェネティックス(Mol.Gen.Genet.)192巻,335
頁(1983)〕が、嫌気性細菌由来の耐熱性、耐アルカリ
性キシラナーゼ遺伝子がクローニングされた報告は無
い。At present, xylanases such as those of the genera Bacteroides, Cryptococcus and Streptomyces are known, and the gene for Bacillus has also been cloned [Molecular and General Genetics (Mol. Gen. Genet.) 192, 335
(1983)], there is no report that a thermostable and alkali-resistant xylanase gene derived from anaerobic bacteria was cloned.
本発明者らは耐熱、耐アルカリ性を有するキシラナー
ゼ生産菌を求め、鋭意研究した結果、耐熱、耐アルカリ
性において優れた性質を有しているキシラナーゼを生産
する菌株を見い出した。本菌株は嫌気性細菌であり、生
産する酵素は優れた性質を有しているが、生産の面にお
いて培養制御など数々の問題点を含むため、まず本発明
者らはキシラナーゼの生産性を高めるために耐熱性嫌気
性細菌のキシラナーゼ遺伝子を担うDNA断片を取り出
し、ついでこのDNA断片をベクターに組み込んだ組換えD
NA及び該組換えDNAを導入した新規な大腸菌を創成し
た。すなわち、本発明は耐熱性嫌気性細菌、更に詳しく
はクロストリジウム・エスピー(Clostridium sp.)HX
−1(本菌株は工業技術院微生物工業技術研究所に寄託
されその寄託番号は微工研菌寄第10129号であり、以下H
X−1菌株と呼ぶ)由来の耐熱、耐アルカリ性キシラナ
ーゼの遺伝情報を有し、第1図に示されるような制限酵
素切断地図を特徴とするDNA断片及びこれを組み込んだ
プラスミド、さらにはこれが導入された大腸菌に関する
ものである。The present inventors have searched for a xylanase-producing bacterium having heat resistance and alkali resistance, and as a result of diligent research, have found a xylanase-producing strain having excellent properties in heat resistance and alkali resistance. This strain is an anaerobic bacterium, and the produced enzyme has excellent properties.However, since the production involves various problems such as culture control, the present inventors first increase the xylanase productivity. For this purpose, a DNA fragment carrying the xylanase gene of a thermotolerant anaerobic bacterium was extracted, and then this DNA fragment was inserted into a recombinant D vector.
A new Escherichia coli transfected with NA and the recombinant DNA was created. That is, the present invention relates to a thermotolerant anaerobic bacterium, more specifically, Clostridium sp.
-1 (This strain was deposited with the National Institute of Microbial Technology, National Institute of Advanced Industrial Science and Technology, and its deposit number is No.
A DNA fragment having the genetic information of a heat- and alkali-resistant xylanase derived from X-1 strain, and characterized by a restriction enzyme cleavage map as shown in FIG. E. coli.
HX−1菌株は本発明者らが自然界から新たに分離した
ものであり、1%キシラン及び1.5%寒天を含むGS培地
(リン酸1カリウム0.15%,リン酸2カリウム0.29%,
硫酸ナトリウム0.13%,イーストエキス0.45%,L−塩酸
システイン0.1%,MOPS(モルホリノ・プロパンスルホン
酸)2.09%,塩化マグネシウム1%、塩化カルシウム0.
15%,硫酸第1鉄0.00125%およびレサズリンナトリウ
ム塩0.0002%を含有)を培養する事によりキシラナーゼ
を生産する。HX−1菌株の形態学的性質は以下の通りで
ある。The HX-1 strain was newly isolated from the natural world by the present inventors, and is a GS medium containing 1% xylan and 1.5% agar (monopotassium phosphate 0.15%, dipotassium phosphate 0.29%,
Sodium sulfate 0.13%, yeast extract 0.45%, L-cysteine hydrochloride 0.1%, MOPS (morpholino-propanesulfonic acid) 2.09%, magnesium chloride 1%, calcium chloride 0.
Xylanase is produced by culturing 15%, ferrous sulfate 0.00125% and resazurin sodium salt 0.0002%). The morphological properties of the HX-1 strain are as follows.
形 : 桿菌 大きさ : 0.5×4.0μm 胞子 : 有り 運動性 : 有り グラム染色 : 陰性 本発明者らの検討結果よりHX−1菌株はクロストリジ
ウム属に属するものと思われる。Shape: Bacillus Size: 0.5 × 4.0 μm Spores: Yes Motility: Yes Gram stain: negative From the results of our studies, the HX-1 strain is considered to belong to the genus Clostridium.
耐熱、耐アルカリ性キシラナーゼの遺伝子情報を担う
染色体DNAはHX−1菌株よりフェノール法などにより分
離精製することができる。The chromosomal DNA carrying the gene information of the heat- and alkali-resistant xylanase can be separated and purified from the HX-1 strain by a phenol method or the like.
本菌株を培養集菌後、リゾチーム処理、SDS処理、プ
ロテアーゼ処理を行い、フェノール処理を繰り返したの
ち、エタノール沈澱法でDNAの糸状の塊を取り出す。さ
らにリボヌクレアーゼ処理を行った後再びエタノール沈
澱により染色体DNAを取り出す。染色体DNAは制限酵素で
完全消化した後、同じく制限酵素(例えばBamH I)で消
化したベクタープラスミドDNA(例えばpUC9)にT4DNAリ
ガーゼを作用させ連結する。After culturing and collecting the strain, lysozyme treatment, SDS treatment, and protease treatment are performed, and the phenol treatment is repeated. Thereafter, a filamentous DNA mass is removed by an ethanol precipitation method. After further ribonuclease treatment, the chromosomal DNA is taken out again by ethanol precipitation. The chromosomal DNA is completely digested with a restriction enzyme, and then ligated to a vector plasmid DNA (eg, pUC9) digested with a restriction enzyme (eg, BamHI) by the action of T4 DNA ligase.
以下に制限酵素としてBamH I及びSau3A I、ベクター
プラスミドDNAとしてpUC9を例として本発明を説明す
る。前記の方法で得られた組換え体DNAをキシラナーゼ
活性の無い大腸菌に培養後、集菌し、塩化カルシウム処
理を行い取り込ませる。Hereinafter, the present invention will be described using BamH I and Sau3A I as restriction enzymes and pUC9 as a vector plasmid DNA as an example. The recombinant DNA obtained by the above method is cultured in Escherichia coli having no xylanase activity, then collected, treated with calcium chloride, and incorporated.
HX−1菌株の耐熱、耐アルカリ性キシラナーゼの遺伝
情報を担うDNA断片を組み込んだプラスミドDNAを保持す
る大腸菌を選び出すには、アンピシリン耐性を保持し、
β−ガラクトシダーゼ活性を喪失した菌株を選択する。
すなわち、アンピシリン及び5−ブロモ−4−クロロ−
3−インドリル−β−D−ガラクトシッドを含んだ培地
(ポリペプトン1.0%、酵母エキス0.5%、塩化ナトリウ
ム0.5%含有、以後L培地と言う)に寒天1.5%を含有し
た培地で培養し、ここで生育する白色コロニーを形成す
る菌株の全てをアンピシリン及びキシランを含んだL培
地(寒天1.5%を含有)に接種し透明環を形成するコロ
ニーを選択する。最終的に確認するためにはL培地でこ
の菌株を培養して酵素を抽出し、そのキシラナーゼ活性
を測定する。To select Escherichia coli carrying a plasmid DNA incorporating a DNA fragment carrying the genetic information of the heat- and alkali-resistant xylanase of the HX-1 strain, the ampicillin resistance must be maintained,
Select strains that have lost β-galactosidase activity.
That is, ampicillin and 5-bromo-4-chloro-
Culture was performed in a medium containing 1.5% agar in a medium containing 1.0% of polypeptone, 0.5% of yeast extract, and 0.5% of sodium chloride (hereinafter referred to as L medium) containing 3-indolyl-β-D-galactoside. All of the strains that form white colonies that grow are inoculated on an L medium (containing 1.5% agar) containing ampicillin and xylan, and colonies that form a transparent ring are selected. For the final confirmation, this strain is cultured in L medium to extract the enzyme, and its xylanase activity is measured.
ついで上記の方法で得られた組換え体プラスミド保持
株よりの組換え体DNAの分離は以下の方法で行う。Next, the recombinant DNA is isolated from the recombinant plasmid-holding strain obtained by the above method by the following method.
培養後、菌体を集め、リゾチーム処理、SDS−NaOH処
理、酢酸カリウム処理を行い、遠心分離して得られた上
澄にイソプロパノールを加えて、プラスミドを抽出す
る。そしてリボヌクレアーゼ処理、フェノール処理、ク
ロロホルム・イソアミルアルコール処理を行ってRNA、
タンパク質を除いた後、エタノール沈澱を行ってプラス
ミドを得る。このようにして得られた組換え体DNAは再
び大腸菌に導入する事ができる。After culturing, the cells are collected, treated with lysozyme, treated with SDS-NaOH, and treated with potassium acetate, and isopropanol is added to the supernatant obtained by centrifugation to extract a plasmid. Then, ribonuclease treatment, phenol treatment, chloroform / isoamyl alcohol treatment are performed,
After removing the protein, ethanol precipitation is performed to obtain a plasmid. The recombinant DNA thus obtained can be introduced again into E. coli.
上記のようにして得られた組換え体プラスミドを保持
する大腸菌を常法により培養し、ソニケーターなどで破
砕することにより、耐熱、耐アルカリ性キシラナーゼの
粗酵素液を得ることができる。Escherichia coli carrying the recombinant plasmid obtained as described above is cultured by a conventional method, and crushed with a sonicator or the like, whereby a crude enzyme solution of a heat- and alkali-resistant xylanase can be obtained.
以下に本発明を実施例により更に明確にする。 Hereinafter, the present invention will be further clarified by examples.
実施例 (1)耐熱性キシラナーゼ遺伝子を担う染色体DNAの抽
出 HX−1菌株をグルコースを0.3%含有したGS培地を用
いて培養し、対数増殖期の終わり近くで集菌する。尚、
培養はグローブボックス(嫌気性培養装置EAN−140、タ
バイ・エスペック社製)によって気相を混合ガス(N2:H
2:CO2=90:5:5)で置換した後、加圧滅菌した培地を使
用した。Example (1) Extraction of Chromosomal DNA Carrying Thermostable Xylanase Gene The HX-1 strain is cultured in a GS medium containing 0.3% glucose, and collected near the end of the logarithmic growth phase. still,
The cultivation is performed using a glove box (anaerobic cultivation device EAN-140, manufactured by Tabai Espec) to mix the gas phase with a mixed gas (N 2 : H).
2 : CO 2 = 90: 5: 5), and a pressure-sterilized medium was used.
得られた菌体に50mMのpH8.0トリス・塩酸緩衝液(50m
MのEDTAを含有)を加えて懸濁し、リゾチーム溶液を加
えて37℃、3分間処理した。ついで1%のラウリル硫酸
ナトリウムを含む50mMのpH7.5トリス・塩酸緩衝液(0.4
MのEDTA、1mg/mlのプロテイナーゼKを含有)を加えて5
0℃、1時間処理する。更にフェノール処理を3回繰り
返し、2,000×gで15分間遠心分離し、その上澄を得
る。得られた上澄に3Mの酢酸ナトリウム及びエタノール
を加えてガラス棒を巻き取る。更に50mMのpH7.5トリス
・塩酸緩衝液(1mMのEDTAを含有)を加え、200μg/mlの
リボヌクレアーゼ溶液を4℃,12時間作用させる。作用
後、クロロホルム処理を行い更に1,000×gで15分間遠
心分離し、上澄部を得る。得られた上澄部に3Mの酢酸ナ
トリウム及びエタノールを加えてガラス棒で巻き取り、
DNAを得る。得られたDNAを50mMのpH7.5トリス・塩酸緩
衝液(1mMのEDTAを含有)で溶解して染色体DNA溶液を得
た。500mlの培養液から594μgの染色体DNAを得た。50 mM of pH 8.0 Tris / HCl buffer (50 mM
M EDTA), and the mixture was suspended. A lysozyme solution was added, followed by treatment at 37 ° C. for 3 minutes. Then, 50 mM pH 7.5 Tris / HCl buffer (0.4% containing 1% sodium lauryl sulfate) was added.
M EDTA, containing 1 mg / ml proteinase K)
Treat at 0 ° C for 1 hour. Further, the phenol treatment is repeated three times, and the mixture is centrifuged at 2,000 × g for 15 minutes to obtain a supernatant. 3 M sodium acetate and ethanol are added to the obtained supernatant, and the glass rod is wound up. Further, 50 mM pH 7.5 Tris / hydrochloric acid buffer (containing 1 mM EDTA) is added, and a 200 μg / ml ribonuclease solution is allowed to act at 4 ° C. for 12 hours. After the action, the mixture is treated with chloroform and further centrifuged at 1,000 × g for 15 minutes to obtain a supernatant. To the obtained supernatant was added 3M sodium acetate and ethanol and wound up with a glass rod,
Obtain DNA. The obtained DNA was dissolved in 50 mM Tris-HCl buffer (pH 7.5, containing 1 mM EDTA) to obtain a chromosomal DNA solution. 594 μg of chromosomal DNA was obtained from 500 ml of the culture solution.
(2)HX−1菌株染色体DNAの制限酵素による部分分解
及びリガーゼ処理 ベクターとしてプラスミドpUC9を使用し、このプラス
ミド50μgにBamH I制限酵素10単位を加え、10mMのpH7.
5トリス・塩酸緩衝液、50mMの塩化ナトリウム、10mMの
塩化マグネシウム及び1mMのジチオスレイトールの溶液6
0μ中で37℃、12時間分解した。反応後、フェノール
・クロロホルム処理を一度行い、エタノール沈澱でプラ
スミドを沈澱させる。得られたプラスミドに1MのpH8.3
トリス・塩酸緩衝液15μにアルカリフォスファターゼ
1単位を加え、60℃で1時間の処理行い、100mM EDTAを
含む溶液(pH7.5)で反応を停止した後、フェノール・
クロロホルム処理を2回行い12,000×gで5分間遠心分
離する。得られた上澄を更に2回クロロホルムで処理し
た後、上記と同じ条件で遠心分離し、上澄部よりエタノ
ール沈澱によって末端処理した完全分解プラスミドpUC9
を得る。(2) Partial digestion of chromosomal DNA of HX-1 strain with restriction enzyme and treatment with ligase Plasmid pUC9 was used as a vector, 10 units of BamHI restriction enzyme was added to 50 μg of this plasmid, and 10 mM of pH7.
5 Tris-HCl buffer, 50 mM sodium chloride, 10 mM magnesium chloride and 1 mM dithiothreitol solution 6
Degraded in 0μ at 37 ° C for 12 hours. After the reaction, phenol / chloroform treatment is performed once, and the plasmid is precipitated by ethanol precipitation. 1M pH 8.3 was added to the obtained plasmid.
One unit of alkaline phosphatase was added to 15 μl of Tris / hydrochloric acid buffer, treated at 60 ° C. for 1 hour, and the reaction was stopped with a solution (pH 7.5) containing 100 mM EDTA.
Perform chloroform treatment twice and centrifuge at 12,000 xg for 5 minutes. The obtained supernatant was further treated twice with chloroform, centrifuged under the same conditions as above, and the completely degraded plasmid pUC9 end-treated by ethanol precipitation from the supernatant.
Get.
(1)で得られた染色体DNAを使用し、このDNA300μ
gにSau3A I制限酵素10単位を加え、6mMのpH7.5トリス
・塩酸緩衝液、50mMの塩化ナトリウム、5mMの塩化マグ
ネシウム及び1mMのジチオスレイトールの溶液4.5ml中で
37℃、1時間分解した。反応後、フェノール・クロロホ
ルム処理を一度行い、エタノール沈澱でDNAを沈殿させ
る。得られたDNAにフェノール・クロロホルム処理を2
回行い12,000×gで5分間遠心分離する。得られた上澄
を更に2回クロロホルムで処理した後、上記と同じ条件
で遠心分離し、上澄部よりエタノール沈澱によってHX−
1株のSau3A I制限酵素分解物を回収し、減圧乾燥後,
水50μに溶解した。Using the chromosomal DNA obtained in (1),
g of 10 g of Sau3A I restriction enzyme, and added to a solution of 6 mM pH 7.5 Tris / HCl buffer, 50 mM sodium chloride, 5 mM magnesium chloride and 1 mM dithiothreitol in 4.5 ml of a solution.
Decomposed for 1 hour at 37 ° C. After the reaction, phenol / chloroform treatment is performed once, and DNA is precipitated by ethanol precipitation. The obtained DNA is treated with phenol / chloroform for 2 hours.
Perform centrifugation at 12,000 xg for 5 minutes. The obtained supernatant was further treated twice with chloroform, centrifuged under the same conditions as above, and HX-precipitated from the supernatant by ethanol precipitation.
One strain of Sau3A I restriction enzyme digest was recovered and dried under reduced pressure.
Dissolved in 50μ of water.
4μの末端処理した完全分解プラスミドpUC9と10μ
の部分分解HX−1株のSau3A I制限酵素分解物を混合
し、緩衝液(66mMの塩化マグネシウム、660μMのATP及
び100mMのジチオスレイトールを含む660mMのpH7.6トリ
ス・塩酸緩衝液)を5μ及び水30μを加えた後、10
00単位のT4DNAリガーゼにより16℃で20時間反応させ
て、ベクターと染色体DNAを連結させた組換えプラスミ
ドを得た。4μ end-treated, completely digested plasmid pUC9 and 10μ
Was mixed with a buffer solution (660 mM pH 7.6 Tris / HCl buffer containing 66 mM magnesium chloride, 660 μM ATP and 100 mM dithiothreitol) mixed with 5 μl of the Sau3A I restriction enzyme digest of the partially decomposed HX-1 strain. And after adding 30μ of water, 10
The mixture was reacted with 00 units of T4 DNA ligase at 16 ° C for 20 hours to obtain a recombinant plasmid in which the vector and the chromosomal DNA were ligated.
(3)組換えプラスミドを用いた大腸菌の形質転換 エシェリシア・コリ(Escherichia coli)JM103株を1
0mlのSOB培地(バクトトリプトン2%、酵母エキス0.5
%、塩化ナトリウム10mM、塩化カリウム2.5mM、塩化マ
グネシウム10mM及び硫酸マグネシウム10mMを含むpH6.8
〜7.0の培地)に接種し、37℃で70分間振とう培養した
のち集菌する。菌体を100mMの冷塩化カルシウム溶液200
mlに懸濁して氷中で20分間放置後、遠心集菌する。更に
100mMの冷塩化カルシウム溶液5mlに懸濁して氷中で24時
間放置後、その0.2mlに組換えプラスミド10μを加え
懸濁して氷中で60分間放置する。ついで42℃で2分間熱
処理し、直ちに冷却する。その後L培地1mlを加えて37
℃で40分間振とう培養する。これを50μg/mlのアンピシ
リンと50μg/mlの5−ブロモ−4−クロロ−3−インド
リル−β−D−ガラクトシッドを含んだL培地(寒天1.
5%を含有)を用いて37℃12時間培養し、白色コロニー
菌株(3500株)の全てを50μg/mlのアンピシリン及び1
%キシランを含んだL培地(寒天1.5%を含有)と50μg
/mlのアンピシリンを含んだL培地(寒天1.5%を含有)
に接種して37℃で12時間培養し、前者の培地に軟寒天
(0.5%寒天,1.5mg/mlリゾチーム及び10mMのトリス・塩
酸緩衝液を含有)10mlを重層し、37℃で12時間放置して
菌体を破壊し続いて60℃で8時間のキシラナーゼ反応を
行い透明環を形成した菌株(1株)を選択した。(3) Transformation of Escherichia coli using recombinant plasmid Escherichia coli JM103
0 ml SOB medium (2% bactotryptone, 0.5% yeast extract)
%, Sodium chloride 10 mM, potassium chloride 2.5 mM, magnesium chloride 10 mM and magnesium sulfate 10 mM
~ 7.0 medium), and after culturing with shaking at 37 ° C for 70 minutes, the cells are collected. Bacteria cells in 100 mM cold calcium chloride solution 200
After suspending in ice and leaving it on ice for 20 minutes, the cells are collected by centrifugation. Further
After suspending in 5 ml of a 100 mM cold calcium chloride solution and allowing to stand on ice for 24 hours, 10 μm of the recombinant plasmid is added to 0.2 ml of the suspension and suspended in ice for 60 minutes. Then heat-treat at 42 ° C. for 2 minutes and cool immediately. Thereafter, 1 ml of L medium was added and 37
Incubate with shaking at 40 ° C for 40 minutes. This was added to an L medium containing 50 μg / ml of ampicillin and 50 μg / ml of 5-bromo-4-chloro-3-indolyl-β-D-galactoside (agar 1.
5%), and all of the white colony strains (3500 strains) were treated with 50 μg / ml ampicillin and 1
L medium containing 1.5% xylan (containing 1.5% agar) and 50μg
medium containing 1.5% / ml ampicillin (containing 1.5% agar)
And incubate at 37 ° C for 12 hours. Overlay the former medium with 10ml of soft agar (containing 0.5% agar, 1.5mg / ml lysozyme and 10mM Tris / HCl buffer) and leave at 37 ° C for 12 hours Then, the cells were destroyed, followed by a xylanase reaction at 60 ° C. for 8 hours to select a strain (1 strain) which formed a transparent ring.
(4)組換え体プラスミドを保持する大腸菌の産生する
キシラナーゼ活性 (3)で選択した形質転換した大腸菌を70μg/mlのア
ンピシリンを含むL培地で培養(37℃、17時間)し集菌
後、50mMの塩化カルシウムを含有する50mMのMOPS緩衝液
(pH6.5)に懸濁して遠心分離する。さらに上記の緩衝
液に懸濁後ソニケーターで細胞を破砕し、遠心分離後、
粗酵素液を得、硫安塩析、透析処理して酵素液を得た。
そのキシラナーゼ活性はキシランを基質として以下のよ
うに測定した。0.2mlのキシラン溶液(1%となるよう
にキシランをpH5.9の0.1Mコハク酸緩衝液に溶解)に0.1
mlの酵素液を加え、60℃で10分間反応後、遊離した糖を
DNS法をもちいて測定した。1分間に1μmoleキシロー
スを遊離する酵素量を1単位とした。組換え体プラスミ
ドを保持する大腸菌の生産する酵素は1000mlの培養液当
りで約110単位であった。(4) Xylanase activity produced by Escherichia coli carrying the recombinant plasmid The transformed Escherichia coli selected in (3) was cultured in an L medium containing 70 μg / ml ampicillin (37 ° C., 17 hours), and collected. Suspend in 50 mM MOPS buffer (pH 6.5) containing 50 mM calcium chloride and centrifuge. After suspending in the above buffer, the cells were disrupted with a sonicator, and centrifuged.
A crude enzyme solution was obtained, salted out with ammonium sulfate, and dialyzed to obtain an enzyme solution.
The xylanase activity was measured as follows using xylan as a substrate. 0.1 ml in 0.2 ml of xylan solution (dissolve xylan in 0.1 M succinate buffer at pH 5.9 to 1%)
Add enzyme solution and react at 60 ° C for 10 minutes.
Measured using the DNS method. The amount of the enzyme that released 1 μmole xylose per minute was defined as one unit. The amount of enzyme produced by Escherichia coli carrying the recombinant plasmid was about 110 units per 1000 ml of culture solution.
(5)繰換え体プラスミドの制限酵素地図の作製 (3)で得られた形質転換株を100μg/mlのアンピシ
リンを含むL培地2000ml中で37℃で14時間振とう培養し
た。培養終了後、遠心分離(1,500×g,10分)して集菌
する。更にリゾチーム溶液〔50mMのグルコース,10mMのE
DTA及び5mg/mlのリゾチームを含有する25mMのトリス・
塩酸緩衝液(pH8.0)〕を加えて、氷中で5分間処理
し、SDS−NaOH溶液(1%のSDSを含有する0.2%水酸化
ナトリウム溶液)を加えて同様に氷中で5分間処理し、
更に酢酸カリウム溶液〔5Mの酢酸カリウム溶液を60mlと
氷酢酸28.5ml及び水11.5mlの混合溶液(pH4.8)〕を加
えてドライアイス・エタノールの冷媒中で凍結し、続い
て室温で解凍する。これを遠心分離(12,000×g,15分)
して上澄を採取する。更に採取した上澄にイソプロパノ
ールを加えてドライアイス・エタノールの冷媒中で凍結
し、続いて室温で解凍する。更にこれを遠心分離(12,0
00×g,5分)してプラスミドを抽出する。これを70%エ
タノールで洗浄・乾燥し、さらに10mMのpH8.0トリス・
塩酸緩衝液(1mMのEDTA含有)(以下TE緩衝液という)
を加えて懸濁し、リボヌクレアーゼ溶液を室温で15分間
作用させる。作用後、フェノール及びクロロホルム:イ
ソアミルアルコール=24:1の混液との等量混合物で処理
し、12,000×gで5分間遠心分離して上澄部を得る。得
られた上澄部を更にクロロホルム:イソアミルアルコー
ル=24:1の混液で処理し、12,000×gで5分間遠心分離
して上澄部を得る。ついで3Mの酢酸ナトリウム及び95%
エタノールを加えて凍結・溶解操作したのち12,000×g
で5分間遠心分離し、沈澱部を得る。得られた沈澱部を
更に70%エタノールで洗浄・遠心分離後TE緩衝液に溶解
し、エチジウムブロマイド−塩化セシウム平衡密度勾配
遠心にかけてプラスミドを得る。得られたプラスミドを
Apa I,BamH I,Bal II,EcoR I,EcoR V,Hind III,Kpn I,P
st I,Pvu II,Sal I,Sac I,Swa I,Xba I,Xho Iなどの制
限酵素で切断し、制限酵素切断地図を作製した。その結
果を第2図に示す。このプラスミドを別のキシラナーゼ
遺伝子の無いエシェリシア・コリJM103株に導入する
と、アンピシリン耐性になった形質転換株はすべて耐熱
・耐アルカリ性キシラナーゼを産生したことから、この
プラスミドに耐熱・耐アルカリ性キシラナーゼの遺伝情
報を担うDNA断片が組み込まれていることが確認され
た。参考例1 HX−1株及び組み換え体由来のキシラナーゼの酵素化
学的性質 A.至適温度 HX−1株及び組換え体より得られるキリアナーゼ酵素
溶液を40℃〜100℃で活性を測定し至適温度を求めたと
ころ、第3図に示すようにいずれも約70℃であった。(5) Preparation of Restriction Enzyme Map of Recombinant Plasmid The transformant obtained in (3) was cultured with shaking in 2000 ml of L medium containing 100 μg / ml ampicillin at 37 ° C. for 14 hours. After completion of the culture, the cells are collected by centrifugation (1,500 × g, 10 minutes). Further, a lysozyme solution (50 mM glucose, 10 mM E
25 mM Tris containing DTA and 5 mg / ml lysozyme
Hydrochloric acid buffer (pH 8.0)], and treated in ice for 5 minutes. An SDS-NaOH solution (0.2% sodium hydroxide solution containing 1% SDS) was added and the mixture was similarly treated in ice for 5 minutes. Process,
Further, a potassium acetate solution [a mixed solution (pH 4.8) of 60 ml of a 5M potassium acetate solution, 28.5 ml of glacial acetic acid and 11.5 ml of water (pH 4.8)] is added, frozen in a dry ice / ethanol refrigerant, and then thawed at room temperature. . Centrifuge this (12,000 xg, 15 minutes)
And collect the supernatant. Further, isopropanol is added to the collected supernatant, frozen in a refrigerant of dry ice / ethanol, and then thawed at room temperature. Further, this is centrifuged (12,0
(00 × g, 5 minutes) to extract the plasmid. This is washed and dried with 70% ethanol, and further diluted with 10 mM pH 8.0 Tris.
Hydrochloric acid buffer (containing 1 mM EDTA) (hereinafter referred to as TE buffer)
Is added and suspended, and the ribonuclease solution is allowed to act at room temperature for 15 minutes. After the action, the mixture is treated with an equal volume mixture of phenol and chloroform: isoamyl alcohol = 24: 1, and centrifuged at 12,000 × g for 5 minutes to obtain a supernatant. The obtained supernatant is further treated with a mixed solution of chloroform: isoamyl alcohol = 24: 1, and centrifuged at 12,000 × g for 5 minutes to obtain a supernatant. Then 3M sodium acetate and 95%
12,000 xg after freezing and thawing by adding ethanol
For 5 minutes to obtain a precipitate. The obtained precipitate is further washed with 70% ethanol, centrifuged, dissolved in a TE buffer, and subjected to ethidium bromide-cesium chloride equilibrium density gradient centrifugation to obtain a plasmid. The resulting plasmid
Apa I, BamH I, Bal II, EcoR I, EcoR V, Hind III, Kpn I, P
It was cut with restriction enzymes such as stI, PvuII, SalI, SacI, SwaI, XbaI, and XhoI to prepare a restriction enzyme cleavage map. The result is shown in FIG. When this plasmid was introduced into another Escherichia coli JM103 strain without the xylanase gene, all the transformants that became ampicillin-resistant produced a thermotolerant and alkali-tolerant xylanase. It was confirmed that the DNA fragment responsible for the DNA was incorporated. REFERENCE EXAMPLE 1 Enzyme chemical properties of xylanase derived from HX-1 strain and recombinant A. Optimal temperature The activity of a chylianase enzyme solution obtained from HX-1 strain and recombinant was measured at 40 ° C. to 100 ° C. When the temperatures were determined, they were all about 70 ° C. as shown in FIG.
B.熱安定性 HX−1株及び組換え体より得られるキシラナーゼを10
0mMのpH5.9コハク酸緩衝液中で50℃〜100℃に20分間放
置しその安定性を測定した。その結果を第4図に示す。
その結果、より高い温度ではHX−1株の方がやや安定で
ある結果となった。B. Thermostable xylanase obtained from HX-1 strain and recombinant
It was left in a 0 mM pH 5.9 succinate buffer at 50 ° C. to 100 ° C. for 20 minutes to measure its stability. The result is shown in FIG.
As a result, the HX-1 strain was slightly more stable at higher temperatures.
C.至適pH 実施例1の(4)に示したキシラナーゼ活性測定法の
コハク酸緩衝液の代わりにユニバーサル緩衝液(ブライ
トン・ロビンソン緩衝液、pH3.0〜pH11.0)を用いてHX
−1株及び組換え体より得られるキシラナーゼの至適pH
を求めたところ、第5図に示すようにいずれも約pH6.0
であった。C. Optimum pH HX was determined using a universal buffer (Brighton-Robinson buffer, pH 3.0 to pH 11.0) instead of the succinate buffer in the xylanase activity measurement method described in (1) of Example 1.
-1 Optimal pH of xylanase obtained from strains and recombinants
Were determined, and as shown in FIG.
Met.
D.各種金属塩の影響 各種金属塩を1mMの濃度になるように添加してその影
響を調べた。その結果を第1表に示す。D. Effects of various metal salts Various metal salts were added to a concentration of 1 mM, and the effects were examined. Table 1 shows the results.
以上のように本酵素はK+,Fe2+,Mg2+,Ca2+,Fe3+,Al3+
には殆ど影響を受けなかったが、Cu2+によって多少の阻
害を受け、Hg2+により阻害された。 As described above, this enzyme is K + , Fe 2+ , Mg 2+ , Ca 2+ , Fe 3+ , Al 3+
Was little affected, but was somewhat inhibited by Cu 2+ and inhibited by Hg 2+ .
酵素化学的性質(至適温度、熱安定性、至適pH、金属
塩の影響等)においてはクロストリジウム・エスピーHX
−1株から得られた酵素と組換え体から得られた酵素と
は同じ性質を示した。Enzyme chemical properties (optimal temperature, thermal stability, optimal pH, effects of metal salts, etc.) on Clostridium sp. HX
-1 and the enzyme obtained from the recombinant showed the same properties.
参考例2 組換え体より得られた酵素のpH安定性 4℃,24時間及び60℃,3時間処理したときの酵素活性を
測定し第6図に示す。組換え体より産生される酵素は耐
熱性でかつ耐アルカリ性である。Reference Example 2 pH Stability of Enzyme Obtained from Recombinant Enzyme activity when treated at 4 ° C. for 24 hours and at 60 ° C. for 3 hours was measured and is shown in FIG. The enzyme produced from the recombinant is heat-resistant and alkali-resistant.
従来培養条件が複雑であった耐熱性嫌気性細菌のキシ
ラナーゼが本発明により培養が容易な大腸菌を使用して
製造できるようになった。更に、耐熱、耐アルカリ性に
おいて優れた酵素を生産することが可能となった。According to the present invention, xylanase of a thermotolerant anaerobic bacterium which has conventionally had complicated culture conditions can be produced using Escherichia coli which is easy to culture. Further, it has become possible to produce an enzyme excellent in heat resistance and alkali resistance.
第1図はクロストリジウム・エスピーHX−1株から得ら
れた耐熱・耐アルカリ性キシラナーゼの遺伝情報を担う
DNA断片であり、長さは5.6Kbである。 第2図は耐熱・耐アルカリ性キシラナーゼの遺伝情報を
担うDNA断片が組み込まれた組換え大腸菌ベクターの制
限酵素切断地図である。 第3図はキシラナーゼの至適温度を示すものであり、−
○−はHX−1株を表し、−●−は組換え体を表す。 第4図はキシラナーゼの熱安定性を示すものであり、−
○−はHX−1株を表し、−●−組換え体を表す。 第5図はキシラナーゼの至適pHを示すものであり、−○
−はHX−1株を表し、−●−は組換え体を表す。 第6図は組換え体のキシラナーゼの各種pHにおける熱安
定性を示すものであり、−○−は4℃,24時間を示し、
−●−は60℃,3時間を示す。Fig. 1 carries the genetic information of thermostable and alkali-tolerant xylanase obtained from Clostridium sp. Strain HX-1.
It is a DNA fragment and is 5.6 Kb in length. FIG. 2 is a restriction map of a recombinant Escherichia coli vector in which a DNA fragment carrying genetic information of heat- and alkali-resistant xylanase has been incorporated. FIG. 3 shows the optimum temperature of xylanase,
−- indicates the HX-1 strain, and-●-indicates the recombinant. FIG. 4 shows the thermostability of xylanase;
−- indicates the HX-1 strain and-● -recombinant. FIG. 5 shows the optimum pH of xylanase,
-Indicates the HX-1 strain, and-●-indicates the recombinant. FIG. 6 shows the thermostability of the recombinant xylanase at various pHs,-○-indicates 4 ° C. for 24 hours,
-●-indicates 60 ° C for 3 hours.
フロントページの続き (51)Int.Cl.6 識別記号 FI C12R 1:19) Continued on the front page (51) Int.Cl. 6 Identification code FI C12R 1:19)
Claims (2)
由来の染色体DNAをSau3A Iで処理して得られる下記に示
される制限酵素地図を有する5.6kbpの遺伝子断片に含ま
れる耐熱、耐アルカリ性キシラナーゼ遺伝子 をエシェルヒア・コリ系ベクターに組み込んだ大腸菌に
より複製できる組換えDNA。1. A heat- and alkali-resistant xylanase gene contained in a 5.6 kbp gene fragment having the following restriction map obtained by treating a chromosomal DNA derived from a heat- and alkali-resistant Clostridium bacterium with Sau3A I: Recombinant DNA that can be replicated by Escherichia coli in which E. coli is integrated into an Escherichia coli-based vector.
由来の染色体がクロストリジウム・エスピーHX−1由来
の染色体である特許請求の範囲第1項記載の組換えDN
A。2. The recombinant DN according to claim 1, wherein the chromosome derived from a heat- and alkali-resistant Clostridium bacterium is a chromosome derived from Clostridium sp. HX-1.
A.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63195143A JP2759209B2 (en) | 1988-08-04 | 1988-08-04 | Recombinant DNA containing xylanase gene |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63195143A JP2759209B2 (en) | 1988-08-04 | 1988-08-04 | Recombinant DNA containing xylanase gene |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0246293A JPH0246293A (en) | 1990-02-15 |
| JP2759209B2 true JP2759209B2 (en) | 1998-05-28 |
Family
ID=16336157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63195143A Expired - Lifetime JP2759209B2 (en) | 1988-08-04 | 1988-08-04 | Recombinant DNA containing xylanase gene |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2759209B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4077158B2 (en) * | 2001-01-10 | 2008-04-16 | 株式会社メニコン | Plant fiber degrading agent and method for treating plant waste using the same |
| CN108018237B (en) * | 2017-12-15 | 2020-12-22 | 武汉轻工大学 | A kind of strain of alkaline xylanase and screening method thereof, and preparation method of xylanase |
-
1988
- 1988-08-04 JP JP63195143A patent/JP2759209B2/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| Appl Microbiol.Biotechnol.27(1987) p.57−63 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0246293A (en) | 1990-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IWASAKI et al. | Molecular cloning of a xylanase gene from Streptomyces sp. No. 36a and its expression in streptomycetes | |
| JPH07508169A (en) | D-N-carbamoyl-amino acid amide hydrolase and hydantoinase | |
| JP2759209B2 (en) | Recombinant DNA containing xylanase gene | |
| JPH10337185A (en) | Novel protein having aspartase activity and gene DNA encoding the protein | |
| JPH062061B2 (en) | Process for producing N-acetylneuraminic acid lyase | |
| EP0513806B1 (en) | Esterase genes, esterase, recombinant plasmids and transformants containing the recombinant plasmid and methods of producing optically active carboxylic acids and their enantiomeric esters using said transformants | |
| CN115725549A (en) | chitinase mutant | |
| JPH05146296A (en) | DNA fragment containing β-galactosidase gene and plasmid incorporating the DNA fragment | |
| JP3463951B2 (en) | Thermostable pyroglutamyl peptidase and its gene | |
| US5149644A (en) | Process for the release of poly(3-hydroxy carboxylic acids) | |
| JPH0829083B2 (en) | Method for producing neutral protease | |
| JP3215117B2 (en) | Recombinant DNA containing cholesterol oxidase gene and production method using the same | |
| JP2024058554A (en) | Genome editing method and composition for genome editing | |
| JPH0246291A (en) | Recombinant dna containing gene of beta-galactose | |
| JPH0679556B2 (en) | Plasmid | |
| JPS6075286A (en) | Recombinant plasmid, bacteria belonging to bacillus genus transformed thereby, and production of xylanase using the same | |
| JPH0255036B2 (en) | ||
| JP3520322B2 (en) | Novel plasmid pPS1M2 and its derivatives from psychrotrophic bacteria | |
| JPH0246292A (en) | Recombinant dna containing cellulase gene | |
| JPH06205682A (en) | Transcription control sequence for expressing bt insecticidal protein | |
| JPS6221515B2 (en) | ||
| JPH0775544B2 (en) | Escherichia coli hybrid plasmid vector that confers sucrose fermentation ability | |
| JPH07143894A (en) | Protein production method | |
| JPH056999B2 (en) | ||
| JPH0284188A (en) | Shuttle vector ycup4 and microorganism strain holding ycup4 in bacteria |